COMMUNIQUÉS West-GlobeNewswire

Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
06/02/2024
CONSHOHOCKEN, Pa., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), today [...]
InnovAge Announces Financial Results for the Fiscal Second Quarter Ended December 31, 2023
06/02/2024
DENVER, Feb. 06, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible [...]
QIAGEN exceeds outlook for Q4 2023, led by 8% CER sales growth in non-COVID products and improved operational profitability
06/02/2024
Q4 2023: Net sales of $509 million (+2% actual rates, +1% constant exchange rates, CER); diluted EPS of $0.42 and adjusted diluted EPS of $0.55 ($0.55 CER vs. $0.53 CER outlook) // FY 2023: Achieved outlook for at least [...]
Corvus Pharmaceuticals Appoints Jeffrey Arcara as Chief Business Officer
06/02/2024
BURLINGAME, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced the appointment of Jeffrey Arcara as Chief Business Officer [...]
Monthly information related to total number of voting rights and shares composing the share capital - January 31, 2024
06/02/2024
Article 223-16 of general regulation of French Autorité des Marchés Financiers Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR001400K4B1- Symbol: PHXM) & Nasdaq Global Select Market [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2024
06/02/2024
Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Places de cotation : Euronext Paris de Euronext (Compartiment C - Code ISIN : FR001400K4B1 – Symbole : PHXM) & Nasdaq Global Select Market aux [...]
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results and Reaffirms 2024 Outlook
06/02/2024
Inspire Reports First Quarter with Operating Income and Year-over-Year Revenue Growth of 40% in the Fourth Quarter MINNEAPOLIS, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a [...]
Celldex to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
06/02/2024
HAMPTON, N.J., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that management will participate in a fireside chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology [...]
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/02/2024
WESTLAKE VILLAGE, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
Cytokinetics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
06/02/2024
SOUTH SAN FRANCISCO, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a [...]
Zylö’s ‘Powered by Z-pods®’ technology incorporated into BosleyMD’s new product line
06/02/2024
The breakthrough product, Revive+ Densifying Foam for hair growth, is now for sale at CVS GREENVILLE, SC, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Zylö’s Z-pod ® topical delivery platform is being used by BosleyMD—the Thinning [...]
Jushi Announces Support of Adult-Use Cannabis in Pennsylvania Governor’s Annual Budget Proposal and Address
06/02/2024
BOCA RATON, Fla., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) ( CSE: JUSH ) ( OTCQX: JUSHF ), a vertically integrated, multi-state cannabis operator, made the following statement [...]
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
06/02/2024
Bagsværd, Denmark, 6 February 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance [...]
For 8th straight year, Indiana Donor Network achieves a record number of lifesaving organ transplants – 1,134
06/02/2024
INDIANAPOLIS, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Support for lifesaving organ donation throughout Indiana rose again to record heights in 2023 as Indiana Donor Network, the federally designated organ recovery [...]
Ibogaine By David Dardashti Offers Free Online Support for Post-Treatment Care
06/02/2024
Free Online Support Aimed To Help Those Who Have Completed Treatment MIAMI, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti is proud to announce the launch of their free online support services to those [...]
Accanto Health promotes experienced HR leader to Chief People Officer
06/02/2024
Katy Kowalsky brings deep human resources expertise to strengthen the employee experience of the health care provider ST. PAUL, Minn., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Accanto Health, a national leader in eating [...]
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2024
06/02/2024
MINNEAPOLIS, MN, US, Feb. 06, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for [...]
Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital
06/02/2024
Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation [...]
Ipsen - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
06/02/2024
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (conformément à l’article L.233-8 II du Code de commerce et à l’article 223-16 du Règlement Général de l’ [...]

Pages